Aloxi and Photophobia - a phase IV clinical study of FDA data

Summary:

Photophobia is reported only by a few people who take Aloxi.

The phase IV clinical study analyzes which people take Aloxi and have Photophobia. It is created by eHealthMe based on reports of 8,512 people who have side effects while taking Aloxi from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 27, 2023

8,512 people reported to have side effects when taking Aloxi.
Among them, 3 people (0.04%) have Photophobia.

What is Aloxi?

Aloxi has active ingredients of palonosetron hydrochloride. eHealthMe is studying from 8,593 Aloxi users for its effectiveness, alternative drugs and more.

What is Photophobia?

Photophobia (extreme sensitivity to light) is found to be associated with 2,480 drugs and 1,747 conditions by eHealthMe.

Number of Aloxi and Photophobia reports submitted per year:

Gender of people who have Photophobia when taking Aloxi *:

female: 33.33 %
male: 66.67 %

Age of people who have Photophobia when taking Aloxi *:

Common drugs people take besides Aloxi *:

Common side effects people have besides Photophobia *:

Weight Decreased: 3 people, 100.00%
Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly): 3 people, 100.00%
Death: 3 people, 100.00%
Metastases To Bone (cancer spreads to bone): 3 people, 100.00%
Joint Pain: 3 people, 100.00%
Chest Pain: 3 people, 100.00%
Nausea (feeling of having an urge to vomit): 3 people, 100.00%
Neck Pain: 3 people, 100.00%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 3 people, 100.00%
Osteonecrosis Of Jaw (death of bone of jaw): 3 people, 100.00%

Common conditions people have *:

Breast Cancer: 2 people, 66.67%
Anaemia (lack of blood): 2 people, 66.67%
Prostate Cancer: 1 person, 33.33%
Osteoporosis (bones weak and more likely to break): 1 person, 33.33%
Diabetes: 1 person, 33.33%
Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Aloxi and have Photophobia?

Check whether Photophobia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Photophobia and when was it recovered:

Photophobia in Aloxi

Expand to all the drugs that have ingredients of palonosetron hydrochloride:

Photophobia and drugs with ingredients of palonosetron hydrochloride

Alternative drugs to, pros and cons of Aloxi:

Aloxi (8,593 reports)

Common Aloxi side effects:

Hair loss: 981 reports
Death: 965 reports
Fatigue (feeling of tiredness): 840 reports
Diarrhea: 817 reports
Nausea and vomiting: 748 reports
Breathing difficulty: 673 reports
Pain: 655 reports
Fever: 628 reports

Browse all side effects of Aloxi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Photophobia treatments and more:

Photophobia (18,277 reports)

COVID vaccines that are related to Photophobia:

Common drugs associated with Photophobia:

All the drugs that are associated with Photophobia:

Photophobia (2,480 drugs)

Common conditions associated with Photophobia:

All the conditions that are associated with Photophobia:

Photophobia (1,747 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on palonosetron hydrochloride (the active ingredients of Aloxi) and Aloxi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.